CONCORDBIO - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 2.3
Show all parameters (20 more)
🧾 Trade Setup
Buy Price: 1,485 ₹. Initial Stop Loss: 1,460 ₹. Target Level 1: 1,520 ₹ - capitalize on momentum based on the DMA crossover and increasing volume. Target Level 2: 1,550 ₹ – if the price sustains above 1,520 ₹ with further increase in volume. Risk management is critical given the high P/E ratio – monitor closely for any signs of profit-taking or negative sentiment.
✅ Positive
High volume today, up 88k shares, indicates significant interest. The recent dip in FII holding may be a buying opportunity as DII is increasing their stake. Price action shows a strong upward momentum based on the MACD and DMA crossover.
⚠️ Limitation
The extremely high P/E ratio of 55 relative to the industry average of 34.8 suggests potential overvaluation, particularly given the recent decline in PAT Qtr. A significant retracement could occur if traders react negatively to this valuation level.
🏭 Industry
The pharmaceutical sector remains volatile due to ongoing regulatory scrutiny and patent expirations impacting several major players. However, investment in innovative research areas like DNA engineering cancer research (as highlighted in the recent news) is a positive catalyst.